المؤلفون: Bly, CA, Gahn, JC, Wielage, RC, Klein, RW, Brown, K, Kalirai, S

المصدر: In Value in Health May 2018 21 Supplement 1:S72-S73

المؤلفون: Mursleen, S, Gahn, JC, Klein, RW, Asukai, Y

المصدر: In Value in Health May 2018 21 Supplement 1:S254-S255

المؤلفون: Kelton, KA, Gahn, JC, Klein, RW, Ramachandran, S, Asukai, Y

المصدر: In Value in Health October-November 2017 20(9):A556-A556

المؤلفون: Chen JV; Medical Decision Modeling, Indianapolis, IN, USA., Gahn JC; Medical Decision Modeling, Indianapolis, IN, USA., Nesheim J; Urovant Sciences, 5281 California Ave, Suite 100, Irvine, CA, 92617, USA. Jeffrey.nesheim@urovant.com., Mudd PN Jr; Urovant Sciences, 5281 California Ave, Suite 100, Irvine, CA, 92617, USA.

المصدر: PharmacoEconomics [Pharmacoeconomics] 2022 Oct; Vol. 40 (10), pp. 979-988. Date of Electronic Publication: 2022 Jul 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9212404 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-2027 (Electronic) Linking ISSN: 11707690 NLM ISO Abbreviation: Pharmacoeconomics

مواضيع طبية MeSH: Urinary Bladder, Overactive*/drug therapy, Adrenergic Agonists/therapeutic use ; Aged ; Cholinergic Antagonists/therapeutic use ; Humans ; Medicare ; Pyrimidinones ; Pyrrolidines ; United States

المؤلفون: Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia. Electronic address: andrew.palmer@utas.edu.au., Si L; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia., Tew M; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Hua X; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Willis MS; The Swedish Institute for Health Economics, Lund, Sweden., Asseburg C; The Swedish Institute for Health Economics, Lund, Sweden., McEwan P; Health Economics and Outcomes Research Ltd., Cardiff, UK., Leal J; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Gray A; Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK., Foos V; IQVIA, Real-World Evidence Solutions, Zaventem, Belgium., Lamotte M; IQVIA, Real-World Evidence Solutions, Zaventem, Belgium., Feenstra T; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands; Groningen University, University Medical Center Groningen, Groningen, The Netherlands., O'Connor PJ; HealthPartners Institute and HealthPartners Center for Chronic Care Innovation, Minneapolis, MN, USA., Brandle M; Department of Internal Medicine, Kantonsspital St. Gallen, St. Gallen, Switzerland., Smolen HJ; Medical Decision Modeling Inc., Indianapolis, IN, USA., Gahn JC; Medical Decision Modeling Inc., Indianapolis, IN, USA., Valentine WJ; Ossian Health Economics and Communications, Basel, Switzerland., Pollock RF; Ossian Health Economics and Communications, Basel, Switzerland., Breeze P; School of Health and Related Research, University of Sheffield, Sheffield, UK., Brennan A; School of Health and Related Research, University of Sheffield, Sheffield, UK., Pollard D; School of Health and Related Research, University of Sheffield, Sheffield, UK., Ye W; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Herman WH; Departments of Internal Medicine and Epidemiology, University of Michigan, Ann Arbor, MI, USA., Isaman DJ; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Kuo S; Departments of Internal Medicine, University of Michigan, Ann Arbor, MI, USA., Laiteerapong N; Department of Medicine, University of Chicago, Chicago, IL, USA., Tran-Duy A; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia., Clarke PM; Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2018 Jun; Vol. 21 (6), pp. 724-731. Date of Electronic Publication: 2018 Apr 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

مواضيع طبية MeSH: Computer Simulation*, Diabetes Mellitus/*economics, Checklist ; Costs and Cost Analysis ; Diabetes Complications/economics ; Diabetes Mellitus/therapy ; Economics, Medical ; Glycated Hemoglobin/analysis ; Humans ; Linear Models ; Quality-Adjusted Life Years ; Reproducibility of Results ; Research Design ; Treatment Outcome

المؤلفون: Smolen LJ; Medical Decision Modeling Inc, Indianapolis, Indiana. Electronic address: leesmolen@mdm-inc.com., Gahn JC; Medical Decision Modeling Inc, Indianapolis, Indiana., Mitri G; Takeda Pharmaceuticals International, Inc., Deerfield, Illinois., Shiozawa A; Takeda Pharmaceuticals International, Inc., Deerfield, Illinois.

المصدر: Clinical therapeutics [Clin Ther] 2016 Jul; Vol. 38 (7), pp. 1710-25. Date of Electronic Publication: 2016 Jun 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-114X (Electronic) Linking ISSN: 01492918 NLM ISO Abbreviation: Clin Ther Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat/*therapeutic use , Gout/*economics , Gout Suppressants/*therapeutic use, Adult ; Aged ; Allopurinol/therapeutic use ; Budgets ; Chronic Disease ; Female ; Gout/complications ; Gout/drug therapy ; Health Care Costs ; Humans ; Male ; Managed Care Programs ; Middle Aged ; Pharmaceutical Services ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/drug therapy ; Renal Insufficiency, Chronic/economics ; United States ; Uric Acid/blood ; Young Adult

المؤلفون: Curtis BH; a Eli Lilly and Company , Indianapolis , IN , USA ;, Curtis S; a Eli Lilly and Company , Indianapolis , IN , USA ;, Murphy DR; b Medical Decision Modeling Inc. , Indianapolis , IN , USA., Gahn JC; b Medical Decision Modeling Inc. , Indianapolis , IN , USA., Perk S; b Medical Decision Modeling Inc. , Indianapolis , IN , USA., Smolen HJ; b Medical Decision Modeling Inc. , Indianapolis , IN , USA., Murray J; a Eli Lilly and Company , Indianapolis , IN , USA ;, Numapau N; a Eli Lilly and Company , Indianapolis , IN , USA ;, Bonner JS; a Eli Lilly and Company , Indianapolis , IN , USA ;, Liu R; a Eli Lilly and Company , Indianapolis , IN , USA ;, Johnson J; a Eli Lilly and Company , Indianapolis , IN , USA ;, Glass LC; a Eli Lilly and Company , Indianapolis , IN , USA ;

المصدر: Journal of medical economics [J Med Econ] 2016 Jun; Vol. 19 (6), pp. 549-56. Date of Electronic Publication: 2016 Feb 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

مواضيع طبية MeSH: Algorithms*, Diabetes Mellitus, Type 2/*drug therapy , Hypoglycemic Agents/*administration & dosage , Hypoglycemic Agents/*economics , Insulin/*administration & dosage , Insulin/*economics, Age Factors ; Aged ; Blood Glucose ; Blood Pressure ; Body Mass Index ; Clinical Trials as Topic ; Comorbidity ; Cost-Benefit Analysis ; Drug Administration Schedule ; Ethnicity ; Female ; Glycated Hemoglobin ; Humans ; Hypoglycemia/prevention & control ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Lipids/blood ; Male ; Meals ; Middle Aged ; Monte Carlo Method ; Nutrition Surveys ; Quality-Adjusted Life Years ; Self Care/methods ; Sex Factors

المؤلفون: Smolen LJ; a a Medical Decision Modeling Inc. , Indianapolis , IN , USA., Gahn JC; a a Medical Decision Modeling Inc. , Indianapolis , IN , USA., Mitri G; b b naviHealth, Inc. Brentwood , TN , USA., Shiozawa A; c c Takeda Pharmaceuticals International, Inc. , Deerfield , IL , USA.

المصدر: Journal of medical economics [J Med Econ] 2016; Vol. 19 (3), pp. 265-76. Date of Electronic Publication: 2015 Nov 23.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9892255 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1941-837X (Electronic) Linking ISSN: 13696998 NLM ISO Abbreviation: J Med Econ Subsets: MEDLINE

مواضيع طبية MeSH: Febuxostat/*economics , Febuxostat/*therapeutic use , Gout/*drug therapy , Gout Suppressants/*economics , Gout Suppressants/*therapeutic use, Adult ; Aged ; Allopurinol/economics ; Allopurinol/therapeutic use ; Cost-Benefit Analysis ; Disease Management ; Female ; Humans ; Male ; Middle Aged ; United States ; Uric Acid/blood

المؤلفون: Smolen HJ; Medical Decision Modeling Inc., 201 N. Illinois St., Ste. 1245, Indianapolis, IN 46204. smolen@mdm-inc.com., Murphy DR, Gahn JC, Yu X, Curtis BH

المصدر: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2014 Sep; Vol. 20 (9), pp. 968-84.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Academy of Managed Care Pharmacy Country of Publication: United States NLM ID: 101644425 Publication Model: Print Cited Medium: Internet ISSN: 2376-1032 (Electronic) Linking ISSN: 23760540 NLM ISO Abbreviation: J Manag Care Spec Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Health Care Costs* , Patient Outcome Assessment*, Diabetes Complications/*prevention & control , Diabetes Mellitus, Type 2/*drug therapy , Hyperglycemia/*prevention & control , Hypoglycemic Agents/*therapeutic use , Insulin/*therapeutic use, Cohort Studies ; Cost Savings ; Costs and Cost Analysis ; Diabetes Mellitus, Type 2/blood ; Diabetes Mellitus, Type 2/complications ; Diabetes Mellitus, Type 2/economics ; Drug Costs ; Drug Monitoring ; Drug Therapy, Combination/economics ; Female ; Glycated Hemoglobin/analysis ; Humans ; Hypoglycemia/chemically induced ; Hypoglycemia/prevention & control ; Hypoglycemic Agents/adverse effects ; Hypoglycemic Agents/economics ; Insulin/adverse effects ; Insulin/economics ; Male ; Metformin/economics ; Metformin/therapeutic use ; Middle Aged ; Monte Carlo Method ; Practice Guidelines as Topic ; Randomized Controlled Trials as Topic

المؤلفون: Furiak NM; Medical Decision Modeling Inc, 8909 Purdue Road Suite 550, Indianapolis, IN 46268, USA. nf@mdm-inc.com., Gahn JC, Klein RW, Camper SB, Summers KH

المصدر: Annals of general psychiatry [Ann Gen Psychiatry] 2012 Nov 16; Vol. 11 (1), pp. 29. Date of Electronic Publication: 2012 Nov 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101236515 Publication Model: Electronic Cited Medium: Internet ISSN: 1744-859X (Electronic) Linking ISSN: 1744859X NLM ISO Abbreviation: Ann Gen Psychiatry Subsets: PubMed not MEDLINE